Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Canyon Capital Advisors disposes of 1,307,500 CBL & Associates Properties common shares for $68.24 million

Canyon Capital Advisors disposes of 1,307,500 CBL & Associates Properties common shares for $68.24 million

BitgetBitget2026/10/08 22:00

Canyon Capital Advisors sold 1,307,500 CBL common shares on Oct. 6, 2026 in an open-market trade. Sale price: $52.19 per share. Beneficial ownership fell to 6,108,794 shares held indirectly following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CBL & Associates Properties Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-418127), on October 08, 2026, and is solely responsible for the information contained therein.

  • Canyon Capital Advisors sold 1,307,500 CBL common shares on Oct. 6, 2026 in an open-market trade.
  • Sale price: $52.19 per share.
  • Beneficial ownership fell to 6,108,794 shares held indirectly following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CBL & Associates Properties Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-418127), on October 08, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21